贝叶斯的方法通过相互排他性来识别癌症途径内的驱动突变
bioRxiv : the preprint server for biology
|June 12, 2025
概括
识别癌症驱动突变是一个挑战. 贝叶斯MAGPIE通过分析突变类型和基因驱动频率来提高准确性,增强癌症基因组学发现.
科学领域:
- 癌症基因组学 癌症基因组学
- 计算生物学 计算生物学
- 统计遗传学 统计遗传学
背景情况:
- 从乘客突变区分驾驶员突变是癌症基因组学的一个关键挑战.
- 计算方法对于分析大型基因组数据集和识别新型驱动程序候选人至关重要.
- 相互排他性分析是一个有吸引力的框架,用于识别参与癌症途径的基因.
研究的目的:
- 引入贝叶斯MAGPIE,一种用于识别癌症驱动基因的增强统计方法.
- 通过结合突变类型信息和建模基因特异性驱动频率来提高驱动突变识别的准确性.
- 为分析癌症基因组数据提供强大的计算工具.
主要方法:
- 贝叶斯MAGPIE使用贝叶斯层次模型框架来改进MAGPIE方法.
- 该方法结合了突变类型信息,以区分基因内的变异的功能影响.
- 使用Dirichlet priori来建模基因特定的驱动频率,控制推断的驱动器集的稀疏性.
主要成果:
- 进行了广泛的模拟研究,以评估BayesMAGPIE的估计偏差和准确性.
- 用八种癌症类型的TCGA数据对原始MAGPIE方法进行了基准测试.
- 改进的方法在识别驱动基因方面表现出更高的准确性.
结论:
- 贝叶斯MAGPIE提供了一种更准确的方法,通过利用突变类型和频率信息来识别癌症驱动突变.
- 该方法与大多数癌症中稀疏的驱动基因组的生物学预期一致.
- 贝叶斯MAGPIE代表了癌症基因组学研究计算工具的重大进步.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K


